Zakiya Rice is a Dermatology physician. OpenAlex indexes 28 publications with 470 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1365 Clifton Rd NE
Ste 1100
Atlanta, GA 303221013
Telephone
404-778-3158Registry record last updated 16 Feb 2018.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Organon LLCProgram year202559 payments$73,024openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202534 payments$42,956openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year202523 payments$42,729openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
50%Corticosteroid50%Triamcinolone Acetonide100%Part D<11 patientsSensory organs
25%Corticosteroid25%Clobetasol Propionate100%Part D<11 patientsAnti-infectives
25%Azole Antifungal25%Ketoconazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 62307 Improvements in Sleep and Pruritus With Abrocitinib Versus Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis: Results From the JADE DARE Study
Journal of the American Academy of Dermatology
2025 - 63449 Combined Skin Clearance and Quality of Life Response in Patients With Moderate-to-Severe Atopic Dermatitis With and Without Prior Systemic Exposure in the JADE Clinical Program
Journal of the American Academy of Dermatology
2025 - 52871 Tapinarof Cream 1% Once Daily is Efficacious for the Treatment of Moderate to Severe Atopic Dermatitis in Patients with Skin of Color Down to 2 Years of Age in Two Pivotal Phase 3 Trials
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”